Profit with us in the 2009 bear market
Research Report
Hotstocked.com has a complete research report available for AEZS stock. Download AEZS report.
Research Report
Get the full report for FREE
Date:Aug 12, 2009
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download AEZS report
  
Example preview: Research report for Aeterna Zentaris, Inc (AEZS) Research report for Aeterna Zentaris, Inc (AEZS) Research report for Aeterna Zentaris, Inc (AEZS) Research report for Aeterna Zentaris, Inc (AEZS)
   

News for Aeterna Zentaris, Inc (AEZS)

Markets Quote Depth/LII Options Charts News Company Financials Insiders Filings Analyst Earnings Historical
News ·  Blogs ·  Filings
Symbol:  | Recent Quotes powered by
  quotemedia.com
News for Aeterna Zentaris Inc.  (AEZS) 
|
$ 0.99   0.0076 (+0.77%) Volume: 44.81 k 3:59 PM EST Nov 20, 2009
Wed, Nov 11, 2009
10:00 AM Isotechnika Pharma reports third quarter 2009 financial results - CNW
8:36 AM Æterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (KRX-0401) at 51st Annual Meeting of the American Society of Hematology - CNW
8:36 AM Æterna Zentaris: son partenaire Keryx Biopharmaceuticals fera une présentation sur affiche portant sur l'activité clinique de perifosine (KRX-0401) à la 51ième assemblée annuelle de l'American Society of Hematology - CNW
8:35 AM AEterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (KRX-0401) at 51st Annual Meeting of the American Society of Hematology - PR Newswire
8:30 AM Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology - PR Newswire
7:02 AM Æterna Zentaris Reports Third Quarter 2009 Financial and Operating Results - CNW
7:01 AM Æterna Zentaris annonce ses résultats financiers et d'exploitation du troisième trimestre de 2009 - CNW
7:00 AM AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results - PR Newswire
Mon, Nov 09, 2009
7:05 AM AEterna Zentaris: Scientific Article Supports Perifosine's Development in Kidney Cancer - PR Newswire
Wed, Nov 04, 2009
7:02 AM AEterna Zentaris to Announce Third Quarter 2009 Financial and Operating Results on November 11, 2009 - PR Newswire
Mon, Nov 02, 2009
7:01 AM AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer - PR Newswire
Fri, Oct 23, 2009
4:15 PM AEterna Zentaris Receives US$5.5 Million from Institutional Investors - PR Newswire
Tue, Oct 20, 2009
1:26 PM Rodman & Renshaw Announces AEterna Zentaris to Raise $5.5 Million from Institutional Investors at $1.20 Per Share - Business Wire
Mon, Oct 19, 2009
5:01 PM AEterna Zentaris to Raise US$5.5 Million from Institutional Investors at US$1.20 Per Share - PR Newswire
7:00 AM AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin (AEZS-130) as First Oral Diagnostic Test for Growth Hormone Deficiency - PR Newswire
Thu, Oct 01, 2009
7:00 AM AEterna Zentaris to Present at BioContact in Quebec City on October 8 - PR Newswire
Wed, Sep 30, 2009
7:00 AM AEterna Zentaris: Thorough QT Trial with Cetrorelix in Benign Prostatic Hyperplasia Meets Primary Endpoint - PR Newswire
Tue, Sep 29, 2009
8:05 AM AEterna Zentaris Partner, Keryx, Presented Updated Phase 2 Data on Perifosine (KRX-0401) for the Treatment of Advanced Metastatic Renal Cell Carcinoma at 8th International Kidney Cancer Symposium in Chicago - PR Newswire
8:01 AM Updated Single Agent Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Carcinoma Reported at the Eighth International Kidney Cancer Symposium - PR Newswire
Mon, Sep 21, 2009
7:01 AM AEterna Zentaris Announces Completion of Phase 1 Study with Oral AEZS-112 in Cancer - PR Newswire
Wed, Sep 16, 2009
8:35 AM AEterna Zentaris Partner, Keryx Biopharmaceuticals, Receives Orphan-Drug Designation for Perifosine (KRX-0401) for the Treatment of Multiple Myeloma - PR Newswire
Tue, Sep 01, 2009
7:00 AM AEterna Zentaris to Present at Upcoming Rodman Renshaw Annual Global Investment Conference - PR Newswire
7:00 AM AEterna Zentaris to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference - CNW
Mon, Aug 17, 2009
2:00 AM AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia - PR Newswire
2:00 AM AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia - CNW
  Page 1 of 10   Next Page

Copyright © QuoteMedia.   Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).   RT   Realtime,  DL+   Realtime BATS,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia.  Terms of Use. 
   
 
Home > Companies > Aeterna Zentaris, Inc
Home | Message boards | Newsletters | Latest Comments | AIM London Stock Exchange | Canadian stocks | Chinese stocks
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2009 hotstocked.com - All rights reserved.